From: Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer
Wnt3a
Wnt5a
β-catenin
MMP-9
VEGFR-2
Primary tumor
51 (61.4%)
58 (69.9%)
70 (84.3%)
45 (54.2%)
30 (36.1%)
Metastatic site
38 (45.8%)
39 (47.0%)
44 (53.0%)
28 (33.7%)
22 (26.5%)
Concordance rate
79.4%
76.2%
68.3%
40.0%